Glucose data and the individualised diabetes consultation. How should we use it? What is enough? Can we ever have too much?

Practical Diabetes

Volumn 31, Issue 4, 2014, Pages 143-148a

  Cranston, Iain C ^a   Nicholson, Eveleigh ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

CGM; Clinical decision making; Data analysis; Data upload; Diabetes; Glycaemic care; SMBG

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; BLOOD GLUCOSE MONITORING; CONSULTATION; CONTINUOUS GLUCOSE MONITORING; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; PATIENT CARE; PATTERN RECOGNITION; REAL TIME CONTINUOUS GLUCOSE MONITORING; SELF MONITORED BLOOD GLUCOSE; SELF MONITORING;

EID: 84902500059     PISSN: 20472897     EISSN: 20472900     Source Type: Journal    
DOI: 10.1002/pdi.1850     Document Type: Article

References (15)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. Turner RC, et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. Lancet 1998;352:837-853.
3. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358:2545-2559.
4. Duckworth W, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39.
5. The ADVANCE Collaborative Group. Intensive blood glucose control and outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572.
6. Davis WA, et al. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Freemantle Diabetes Study. Diabetologia 2007; 50:510-515. (Pubitemid 46215491)
7. Farmer A, et al. Impact of self monitoring blood glucose in the management of patients with noninsulin treated diabetes: open parallel group randomized trial. BMJ 2007;335;132.
8. Schwedes U, et al. Meal-related structured selfmonitoring of blood glucose: effect on diabetes control in non-insulin treated type 2 diabetic patients. Diabetes Care 2002;25:1928-1932. (Pubitemid 41071046)
9. Barnett AH, et al. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multi-centre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab 2008;10:1239-1247.
10. Polonsky WH, et al. Structured self-monitoring of blood glucose significantly reduces A1c levels in poorly controlled, non-insulin treated type 2 diabetes. Results from the Structured Testing Program Study. Diabetes Care 2011;34:262-267.
11. Clarke SF, Foster Jr. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci 2012;69:83-93.
12. Ziegler R, et al. Use of an insulin bolus advisor improves glycaemic control in multiple daily injection (MDI) therapy patients with suboptimal glycaemic control: first results from the ABACUS trial. Diabetes Care 2013; 36:3613-3619.
13. Bergenstal RM, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 2013:15:198-211, AND J Diabetes Sci Technol 2013;7:562-78.
14. Bergenstal RM, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). J Diabetes Sci Technol 2013;7:562-578.
15. Pickup J, et al. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011;343:d3805.